cobas® TaqScreen DPX Test
Roche's cobas® TaqScreen DPX Test is a real-time polymerase chain reaction (PCR) assay that detects parvovirus B19 (B19V) and hepatitis A virus (HAV) in human plasma.
The CE-IVD version is an in-process test which simultaneously quantifies B19V DNA and detects HAV RNA. The test has a limit of detection of 11.5 IU/mL and a linear range from 75–3E8 IU/mL for B19V DNA. The test has a limit of detection of 1.1 IU/mL for HAV RNA.
This test is not an FDA-licensed product. It is available to US laboratories with appropriate FDA authorization.
For a full listing of Roche Molecular Diagnostics products, see http://molecular.roche.com.